top of page
Lab Experiments

Your Next Generation 

Radiopharmaceutical

Platform

Paper Abstract

BEHIND THE SCIENCE

Confidential z-alpha Introduction_2024 (

A company that is led by a seasoned management team with deep expertise
in oncology and radiopharmacuticals

DukeRadiology-Michael_Zalutsky0209croppe
RAD_OutlookProfilePicture_edited_edited_
Michael Zalutsky, PhD
CSO, Professor Radiology,
Duke University
Martin Pomper, MD, PhD
Senior Director of Translation
Chair Radiology, University Texas
at South Western
Test Tubes
Microscope_edited.jpg
GettyImages-1212470616_edited.jpg
Screenshot_31-5-2024_10208_.jpeg
Screenshot_3-6-2024_114921_.jpeg
Screenshot_31-5-2024_104848_.jpeg
Screenshot_3-6-2024_115452_.jpeg
Water Samples

Z-Alpha

The leader in utilizing the next generation Alpha-Emitter Astatine

  • Ideal nuclear decay scheme for clinical efficacy and safety with one alpha-particle per Astatine-211 decay

  • Abundant polonium x-rays for direct clinical imaging 

  • Short 7.2 hour half-life ideal for patient/hospital/production safety

  • Properties similar to iodine so ideal for conjugation for large AND small molecules

Paper Abstract

BLUE CHIP INVESTORS

Investors.jpg
bottom of page